The transmembrane form of CD95L was originally detected at the surface of activated lymphocytes (45) and natural killer (NK) cells (46), where it not only contributes to eliminating tumor and infected cells but also kills T-cells through a process called activation-induced cell death (AICD) and dendritic cells (47). This evidence concerns the gene FASLG and neoplasm.